Fiscal year 2019 FDA medical device fees released


Pexels.com

Fee rates and payment instructions for companies submitting new medical device applications to the federal Food and Drug Administration have been released for fiscal year 2019, which began on Oct. 1, 2018.

The fees help the agency make the regulatory process more efficient so that such devices can get approved for use in the U.S. market more quickly, according to the FDA. The fees can change annually based on increases in government payroll costs and inflation.

Companies that qualify as small businesses get reduced rates. To be approved for the reduced rates, a business and its affiliates must have gross sales not exceeding $100 million for the most recent tax year, the FDA reports on its website.

Under the federal Food, Drug and Cosmetics Act, different types of medical device submission fees are determined based on a percentage of the standard charge for a premarket application. Such a premarket submission is defined as a premarket approval application (PMA), product development protocol (PDP) or a biologics license application, or BLA.

---

Medical Device User Fees for FY 2019

Application Fee TypeStandard Fee (% of Standard Fee for Premarket Application)FY 2019 Standard FeeFY 2019 Small Business Fee
Premarket applicationBase fee specified in statute$322,147$80,537
Premarket report100$322,147$80,537
Efficacy supplement (to an approved biologics

license application)

100$322,147$80,537
Panel-track supplement75$241,610$60,403
De novo classification request30$96,644$24,161
180-day supplement15$48,322$12,081
Real-time supplement7$22,550$5,638
Premarket notification submission3.4$10,953$2,738
30-day notice1.6$5,154$2,577
Request for classification information1.35$4,349$2,175
Annual fee for periodic reporting on a class III device (one that is implanted or presents a potentially high patient risk)3.5$11,275$2,819
Annual establishment registration fee (to be paid

by the establishment engaged in the manufacture, preparation, propagation, compounding or

processing of a device)

Base fee specified in statute$4,884$4,884
Source: Food and Drug Administration

More News

FDA Reporter